Aeon Global Health™ Launches BDx Advantage™ - Extensive Blood Diagnostic Testing
GAINESVILLE, Ga., Feb. 23, 2017 /PRNewswire/ -- Authentidate Holding Corp. (OTC: ADAT), a provider of genetic hereditary cancer, molecular microbiology, pharmacogenomics, toxicology testing services, and secure, web-based software applications and telehealth products for healthcare organizations, today announced the addition of BDx AdvantageTM Blood Diagnostic testing to their growing portfolio of services.
Blood tests may be performed for several different reasons. Blood may be analyzed to diagnose certain health conditions or possibly rule out conditions based on symptoms. In addition, blood tests may help monitor existing health conditions. Finally, they may be used to check the function of organs like the liver or kidneys if patients are taking medications that may affect them.
Aeon's comprehensive BDx AdvantageTM menu includes:
- Metabolic, hepatic and renal function testing
- Advanced lipid profiles
- General chemistry and extensive hormone testing
Some of the benefits of Aeon's BDx Advantage™ include the extensive testing options and the use of the most advanced technology and high throughput instrumentation available. Furthermore, Aeon has the ability to handle thousands of samples per day, while maintaining a quick turnaround time of 24 hours.
"By expanding into blood diagnostic testing, we can leverage our technical knowledge to provide accurate results for our customers. This complements our extensive range of testing capabilities, allowing physicians to determine the best course of treatment for their patients." – Dr. James Canner, Ph.D., Laboratory Operations Director.
Dr. Shawn Desai, Ph.D., J.D., Chief Technology Officer comments, "We have several thousand physician clients across the United States that are currently using our specialty testing services, and many of them have inquired about using Aeon for BDx. We believe this will lead to rapidly increasing testing volumes in this area, especially since we are using the latest in testing equipment."
"My excitement is building as Aeon Global Health begins blood testing using the state of the art Roche Cobas 6000 high throughput chemistry analyzer," – comments John Andrews, MLT (AMT), Head of the Blood Testing Department. "The analyzer can perform more than 1000 chemistry tests and 250 immunoassays per hour with a wide test menu for the clients that we serve."
For more information, visit: http://aeonglobalhealth.com/
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aeon-global-health-launches-bdx-advantage---extensive-blood-diagnostic-testing-300412701.html
SOURCE Aeon Global Health